Shed Rx vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?
An independent, side-by-side comparison of shed-rx and Hims for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.
In-Depth Comparison
By sarah-chen · Last updated April 15, 2026
Shed Rx vs Hims for GLP-1 Weight Loss (2026)
Shed Rx is a dedicated weight loss telehealth platform; Hims is a men's health and wellness brand with a weight loss GLP-1 offering. Both operate primarily as cash-pay programs with compounded semaglutide and tirzepatide access. The comparison reveals differences in focus, clinical depth, and which patient profile each serves best.
Quick Comparison
| Shed Rx | Hims | |
|---|---|---|
| Monthly cost | ~$99–179/month | ~$199/month |
| Primary focus | Weight loss | Men's health (hair, ED, mental health, weight) |
| Semaglutide access | Yes — compounded | Yes — compounded |
| Tirzepatide access | Yes — compounded | Yes — compounded |
| Brand-name GLP-1 | Limited | Limited |
| Insurance navigation | No | No |
| Coaching | Limited | Limited |
| Prescriber type | Licensed providers | Licensed providers |
| Provider communication | Async primarily | Async primarily |
| Male-specific focus | No (gender-neutral) | Yes — men's health context |
| Other services | Weight loss focused | Hair loss, ED, mental health, skincare |
Shed Rx: Dedicated Weight Loss Platform
Shed Rx operates specifically as a weight management telehealth service. The intake and ongoing care focus on GLP-1 prescribing, medication management, and weight loss support.
Shed Rx strengths:
- Lower price point than Hims (~$99–179 vs ~$199)
- Dedicated weight loss focus — the clinical team is weight management-oriented
- Tirzepatide available at compounded pricing
- Straightforward intake and prescription process
- Gender-neutral — open to women and men equally
Shed Rx limitations:
- No insurance navigation
- Limited coaching or behavioral support infrastructure
- Newer platform with smaller track record than established competitors
- No access to brand-name GLP-1 if compounding changes
Hims: Men's Health Brand with Weight Loss Add-On
Hims started in men's health (hair loss, ED, mental health) and added weight loss as a product line. The brand positioning appeals to men who want a single platform managing multiple health concerns. The weight loss program offers compounded semaglutide and tirzepatide with the Hims brand experience — clean app, easy ordering, consistent packaging.
Hims strengths:
- Strong brand with existing male customer trust
- App experience is polished and consumer-friendly
- Can combine weight loss with hair loss or ED treatment in one subscription
- Large company with supply chain stability
Hims limitations:
- Higher monthly cost than Shed Rx and many competitors (~$199/month)
- Weight loss is not the company's core clinical expertise
- No insurance navigation
- Limited clinical depth beyond prescription and refills
- Designed primarily for male customers (Hers is the women's brand)
Pricing Comparison
| Plan | Shed Rx (Annual) | Hims (Annual) |
|---|---|---|
| Compounded semaglutide program | ~$1,188–2,148 | ~$2,388 |
| Compounded tirzepatide program | ~$1,788–2,148 | ~$2,388+ |
| Annual savings vs Hims (low end) | $240–1,200 less | Baseline |
At the lower end of Shed Rx pricing ($99/month), the annual savings vs Hims ($199/month) is ~$1,200 — a meaningful difference for a medication program likely to continue 12+ months.
Who Each Program Serves Best
Shed Rx is better if you:
- Want the lowest-cost dedicated weight loss telehealth option
- Are a woman or don't want a male-branded experience
- Want a clean, focused weight management program without other health products
- Are price-sensitive and don't need premium brand experience
Hims is better if you:
- Are a man already using Hims for hair loss, ED, or other services and want to add weight management
- Value the Hims brand and app experience
- Want convenience of consolidating multiple men's health needs in one subscription
- Are comfortable paying a premium for the brand and platform quality
The Compounding Regulatory Caveat
Both platforms rely on compounded semaglutide and tirzepatide. As the regulatory environment around compounding has evolved in 2025–2026, both platforms have navigated FDA guidance — but neither offers the regulatory stability of brand-name medication. Patients should understand that compounding availability could change and have a contingency plan.
Related Resources
- Shed Rx vs Henry Meds — Shed Rx vs the lowest-cost option
- Hims Weight Loss Review — full program review
- Hims vs Ro — Hims vs established full-service platform
- Compounded vs Brand-Name GLP-1 — regulatory status explained
- Best Cash-Pay GLP-1 Programs — full ranking of affordable options
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →